Physician Assistant · Bronx, NY
NPI
1689933095
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2590 Frisby Ave
Bronx, NY, 10461
Phone (718) 409-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,368
156 services
Medicare patients, 2024
111
Average age 75
Drug cost, 2024
$2.0M
5,034 prescriptions
Company payments, 2025
$674
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica I Fuentes was code 99213 (office e&m - established), 62 times for 51 patients. In total Jessica I Fuentes billed 156 services in 7 codes, and Medicare paid $8,368.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 62 | 51 | $53.87 | $3,340 |
| 92014 Ophthalmological E&M | Office | 56 | 56 | $63.49 | $3,555 |
| 92250 Angiography | Office | 21 | 21 | $24.70 | $519 |
By year: 2022 $7,236 for 89 services; 2023 $32K for 455 services; 2024 $8,368 for 156 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica I Fuentes prescribed most often to Medicare patients was Restasis (Cyclosporine), with 1,155 prescriptions and refills. In total Jessica I Fuentes wrote 5,034 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 1,155 | 1,818 | 314 | $1.1M |
| Erythromycin Erythromycin Base | 995 | 998 | 324 | $9,095 |
| Latanoprost Generic | 689 | 1,112 | 154 | $6,328 |
| Xiidra Lifitegrast | 471 | 714 | 124 | $467K |
| Azelastine Hcl Generic | 327 | 368 | 96 | $3,948 |
| Lumigan Bimatoprost | 240 | 463 | 71 | $129K |
| Brimonidine Tartrate Generic | 184 | 297 | 50 | $6,108 |
| Combigan Brimonidine Tartrate/Timolol | 178 | 258 | 44 | $55K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 127 | 214 | 39 | $2,223 |
| Dorzolamide Hcl Generic | 105 | 174 | 24 | $1,677 |
| Miebo Perfluorohexyloctane/Pf | 90 | 99 | 55 | $71K |
| Cyclosporine Generic | 85 | 153 | 37 | $34K |
| Timolol Maleate Generic | 65 | 98 | 17 | $580 |
| Restasis Multidose Cyclosporine | 56 | 122 | 20 | $72K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 36 | 57 | 19 | $6,851 |
Brand drugs: 2,544 claims; generic drugs: 2,490 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica I Fuentes $674 ($674 in general payments such as food, travel and fees) from 6 companies. The largest payer was Alcon Vision LLC with $319.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.